BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

541 related articles for article (PubMed ID: 27225336)

  • 1. Dienogest compared with gonadotropin-releasing hormone agonist after conservative surgery for endometriosis.
    Takaesu Y; Nishi H; Kojima J; Sasaki T; Nagamitsu Y; Kato R; Isaka K
    J Obstet Gynaecol Res; 2016 Sep; 42(9):1152-8. PubMed ID: 27225336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maintenance therapy with dienogest following gonadotropin-releasing hormone agonist treatment for endometriosis-associated pelvic pain.
    Kitawaki J; Kusuki I; Yamanaka K; Suganuma I
    Eur J Obstet Gynecol Reprod Biol; 2011 Aug; 157(2):212-6. PubMed ID: 21474232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gonadotrophin-releasing hormone analogue or dienogest plus estradiol valerate to prevent pain recurrence after laparoscopic surgery for endometriosis: a multi-center randomized trial.
    Granese R; Perino A; Calagna G; Saitta S; De Franciscis P; Colacurci N; Triolo O; Cucinella G
    Acta Obstet Gynecol Scand; 2015 Jun; 94(6):637-45. PubMed ID: 25761587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dienogest vs GnRH agonists as postoperative therapy after laparoscopic eradication of deep infiltrating endometriosis with bowel and parametrial surgery: a randomized controlled trial.
    Ceccaroni M; Clarizia R; Liverani S; Donati A; Ceccarello M; Manzone M; Roviglione G; Ferrero S
    Gynecol Endocrinol; 2021 Oct; 37(10):930-933. PubMed ID: 34036845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gonadotropin-releasing hormone agonist with add-back treatment is as effective and tolerable as dienogest in preventing pain recurrence after laparoscopic surgery for endometriosis.
    Lee DY; Lee JY; Seo JW; Yoon BK; Choi D
    Arch Gynecol Obstet; 2016 Nov; 294(6):1257-1263. PubMed ID: 27549091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of effect of preoperative dienogest and gonadotropin-releasing hormone agonist administration on laparoscopic cystectomy for ovarian endometriomas.
    Ozaki R; Kumakiri J; Jinushi M; Ikuma S; Murakami K; Kawasaki Y; Kitade M
    Arch Gynecol Obstet; 2020 Oct; 302(4):969-976. PubMed ID: 32661756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A gonadotrophin-releasing hormone agonist compared with expectant management after conservative surgery for symptomatic endometriosis.
    Vercellini P; Crosignani PG; Fadini R; Radici E; Belloni C; Sismondi P
    Br J Obstet Gynaecol; 1999 Jul; 106(7):672-7. PubMed ID: 10428523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of Post-Operative Medication to Prevent Recurrence of Endometrioma: Cyclic Oral Contraceptive (OC) After Gonadotropin-Releasing Hormone (GnRH) Agonist Versus Dienogest.
    Choi SH; Kim SE; Lim HH; Lee DY; Choi D
    J Korean Med Sci; 2022 Jul; 37(26):e207. PubMed ID: 35790209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postoperative administration of dienogest plus estradiol valerate versus levonorgestrel-releasing intrauterine device for prevention of pain relapse and disease recurrence in endometriosis patients.
    Morelli M; Sacchinelli A; Venturella R; Mocciaro R; Zullo F
    J Obstet Gynaecol Res; 2013 May; 39(5):985-90. PubMed ID: 23551827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A gonadotropin-releasing hormone agonist versus a low-dose oral contraceptive for pelvic pain associated with endometriosis.
    Vercellini P; Trespidi L; Colombo A; Vendola N; Marchini M; Crosignani PG
    Fertil Steril; 1993 Jul; 60(1):75-9. PubMed ID: 8513962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness Analysis of Dienogest Compared With Gonadotropin-Releasing Hormone Agonist After Conservative Surgery for Endometriosis in China.
    Dai Y; Shi B; Huang X; Duan J; Qiu Y; Ha C; Huang R; Xiao D; Liu J; Xuan J
    Clin Ther; 2021 Aug; 43(8):1276-1284.e1. PubMed ID: 34384611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the efficacy of diegnogest and levonorgestrel-releasing intrauterine system after laparoscopic surgery for endometriosis.
    Lee KH; Jung YW; Song SY; Kang BH; Yang JB; Ko YB; Lee M; Han HY; Yoo HJ
    J Obstet Gynaecol Res; 2018 Sep; 44(9):1779-1786. PubMed ID: 29974633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dienogest is as effective as triptorelin in the treatment of endometriosis after laparoscopic surgery: results of a prospective, multicenter, randomized study.
    Cosson M; Querleu D; Donnez J; Madelenat P; Konincks P; Audebert A; Manhes H
    Fertil Steril; 2002 Apr; 77(4):684-92. PubMed ID: 11937116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical study on the effectiveness and safety of combined laparoscopy and gonadotropin-releasing hormone agonist in the treatment of endometriosis].
    Song JH; Lu H; Zhang J; Li B
    Zhonghua Fu Chan Ke Za Zhi; 2013 Aug; 48(8):584-8. PubMed ID: 24199923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of long-term use of combined oral contraceptive after gonadotropin-releasing hormone agonist plus add-back therapy versus dienogest to prevent recurrence of ovarian endometrioma after surgery.
    Seo JW; Lee DY; Kim SE; Yoon BK; Choi D
    Eur J Obstet Gynecol Reprod Biol; 2019 May; 236():53-57. PubMed ID: 30884336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beneficial effects of dienogest on uterine myoma volume: a retrospective controlled study comparing with gonadotropin-releasing hormone agonist.
    Ichigo S; Takagi H; Matsunami K; Suzuki N; Imai A
    Arch Gynecol Obstet; 2011 Sep; 284(3):667-70. PubMed ID: 21052701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of dienogest on pain and ovarian endometrioma occurrence after laparoscopic resection of uterosacral ligaments with deep infiltrating endometriosis.
    Yamanaka A; Hada T; Matsumoto T; Kanno K; Shirane A; Yanai S; Nakajima S; Ebisawa K; Ota Y; Andou M
    Eur J Obstet Gynecol Reprod Biol; 2017 Sep; 216():51-55. PubMed ID: 28728071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrence of uterine adenomyosis after administration of gonadotropin-releasing hormone agonist and the efficacy of dienogest.
    Matsushima T; Akira S; Yoneyama K; Takeshita T
    Gynecol Endocrinol; 2020 Jun; 36(6):521-524. PubMed ID: 31661345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dienogest. A possible conservative approach in bladder endometriosis. Results of a pilot study.
    Angioni S; Nappi L; Pontis A; Sedda F; Luisi S; Mais V; Melis GB
    Gynecol Endocrinol; 2015 May; 31(5):406-8. PubMed ID: 25776993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term medical management of endometriosis with dienogest and with a gonadotropin-releasing hormone agonist and add-back hormone therapy.
    Bedaiwy MA; Allaire C; Alfaraj S
    Fertil Steril; 2017 Mar; 107(3):537-548. PubMed ID: 28139239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.